Scilex Holding Company (SCLX)
NASDAQ: SCLX · IEX Real-Time Price · USD
1.080
-0.030 (-2.70%)
At close: May 31, 2024, 4:00 PM
1.150
+0.070 (6.48%)
After-hours: May 31, 2024, 6:50 PM EDT
Scilex Holding Company Market Cap
Scilex Holding Company has a market cap or net worth of $195.69 million as of May 31, 2024. Its market cap has decreased by -80.53% in one year.
Market Cap
195.69M
Enterprise Value
305.91M
1-Year Change
-80.53%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since January 7, 2021, Scilex Holding Company's market cap has increased from $127.60M to $195.69M, an increase of 53.36%. That is a compound annual growth rate of 13.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 195.70M | -2.69% |
May 30, 2024 | 201.10M | -2.66% |
May 29, 2024 | 206.60M | 5.57% |
May 28, 2024 | 195.70M | -4.40% |
May 24, 2024 | 204.70M | 3.65% |
May 23, 2024 | 197.50M | -5.23% |
May 22, 2024 | 208.40M | 3.63% |
May 21, 2024 | 201.10M | -8.26% |
May 20, 2024 | 219.20M | 34.40% |
May 17, 2024 | 163.10M | 3.49% |
May 16, 2024 | 157.60M | 6.34% |
May 15, 2024 | 148.20M | 2.21% |
May 14, 2024 | 145.00M | -0.62% |
May 13, 2024 | 145.90M | 17.85% |
May 10, 2024 | 123.80M | -10.22% |
May 9, 2024 | 137.90M | -2.06% |
May 8, 2024 | 140.80M | -7.61% |
May 7, 2024 | 152.40M | 5.91% |
May 6, 2024 | 143.90M | 0.70% |
May 3, 2024 | 142.90M | 1.42% |
May 2, 2024 | 140.90M | -0.98% |
May 1, 2024 | 142.30M | 0.35% |
Apr 30, 2024 | 141.80M | -7.44% |
Apr 29, 2024 | 153.20M | 4.79% |
Apr 26, 2024 | 146.20M | 2.17% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Semler Scientific | 207.24M |
Boundless Bio | 202.96M |
NeuroPace | 198.79M |
Delcath Systems | 195.89M |
Inogen | 195.69M |
Omeros | 194.69M |
Zevra Therapeutics | 194.62M |
TriSalus Life Sciences | 194.46M |